Winship Melanoma & Cutaneous Oncology Symposium 2024

Winship Melanoma & Cutaneous Oncology Symposium 2024 The Winship Cancer Institute Melanoma and Cutaneous Oncology Symposium serve as a valuable forum for the presentation and discussion of newly available data. Participants will be provided with an update on practice-changing data in a practical and interactive format, fostering discussion and impacting clinical outcomes for patients with melanoma and non-melanoma skin cancer.

TARGET AUDIENCE

This activity is specifically designed to meet the needs of dermatologists, medical, surgical, and radiation oncologists, hematologists, residents, fellows, advanced practice providers, nurses, and pharmacists.

CONTINUING EDUCATION CREDIT

The Emory University School of Medicine designates this live activity for a maximum of 6.5 hours.

The Emory University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

LEARNING OBJECTIVES

After successful completion of this educational activity, participants should be able to:

• Identify recent advances and current status of neoadjuvant and adjuvant treatment of melanoma
• Discuss recent advances in surgical management of the nodal basin in melanoma
• Describe pathologic evaluation of pigmented lesions and regional lymph nodes, including evaluation of nodes after neoadjuvant treatment
• Discuss new insights into melanoma and detection and prevention
• Discuss current approaches to management of non-melanoma skin cancers
• Describe approaches to treatment of anti-PD-1 refractory melanoma
• Describe recent approaches to multidisciplinary management of Merkel cell carcinoma

COURSE DIRECTORS

• David H. Lawson, MD, Winship Cancer Institute of Emory University
• Michael Lowe, MD, MA, Winship Cancer Institute of Emory University